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Protocol
AbstrACt
Introduction Saltwater intrusion and salinisation have 
contributed to drinking water scarcity in many coastal 
regions globally, leading to dependence on alternative 
sources for water supply. In southwest coastal Bangladesh, 
communities have few options but to drink brackish 
groundwater which has been associated with high 
blood pressure among the adult population, and pre-
eclampsia and gestational hypertension among pregnant 
women. Managed aquifer recharge (MAR), the purposeful 
recharge of surface water or rainwater to aquifers to bring 
hydrological equilibrium, is a potential solution for salinity 
problem in southwest coastal Bangladesh by creating a 
freshwater lens within the brackish aquifer. Our study aims 
to evaluate whether consumption of MAR water improves 
human health, particularly by reducing blood pressure 
among communities in coastal Bangladesh.
Methods and analysis The study employs a stepped-
wedge cluster-randomised controlled community trial design 
in 16 communities over five monthly visits. During each visit, 
we will collect data on participants’ source of drinking and 
cooking water and measure the salinity level and electrical 
conductivity of household stored water. At each visit, we will 
also measure the blood pressure of participants ≥20 years 
of age and pregnant women and collect urine samples for 
urinary sodium and protein measurements. We will use 
generalised linear mixed models to determine the association 
of access to MAR water on blood pressure of the participants.
Ethics and dissemination The study protocol has 
been reviewed and approved by the Institutional Review 
Boards of the International Centre for Diarrheal Disease 
Research, Bangladesh (icddr,b). Informed written consent 
will be taken from all the participants. This study is 
funded by Wellcome Trust, UK. The study findings will be 
disseminated to the government partners, at research 
conferences and in peer-reviewed journals.
trial registration number NCT02746003; Pre-results.
IntroduCtIon
Background and rationale
Saltwater intrusion and salinisation have 
increased groundwater salinity in many 
coastal aquifers and small islands across 
the world.1–5 This is driven by a number of 
climatological and anthropogenic factors 
including global warming, increased cyclones 
and tidal surges, reduced river discharge 
and increased groundwater abstraction in 
excess of recharge.6–8 Communities in many 
strengths and limitations of this study
 ► This is the first study to evaluate the health impact 
of managed aquifer recharge (MAR) in southwest 
coastal Bangladesh.
 ► The stepped-wedge trial ensures we will have 
counterfactual data as well as gradual access to 
MAR water in all communities.
 ► Objective measurement of exposure (drinking water 
salinity) and outcomes (urinary sodium and blood 
pressure).
 ► The magnitude of exposure will vary geographically 
and across time period. Therefore, MAR water 
salinity will differ across communities at a single 
point of time, and also for the same community at 
different points of time.
 ► Compliance of the intervention may be different 
across sites and for individuals of different 
socioeconomic status.
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coastal regions rely on groundwater as their main source 
of drinking water9 as well as freshwater for domestic, 
agricultural and industrial purposes.10 Nearly half of the 
world’s population resides in coastal areas3 and 10% of 
these live in low-lying coastal areas where surface eleva-
tion is generally <10 m above mean sea level.11 Salinisa-
tion in coastal areas is expected to increase in the future 
because of increased groundwater withdrawal due to 
population and economic growth and sea level rise.3 As 
the world's population and economic activities continue 
to grow, groundwater supplies are progressively under 
threat of depletion, which increases the importance of 
monitoring, management and conservation of coastal 
freshwater aquifers.12 13
One approach to minimise the impact of groundwater 
salinisation is to enhance groundwater recharge into 
coastal aquifers.14 Managed aquifer recharge (MAR) is 
an approach to artificially promote freshwater recharge 
to increase storage. MAR involves infiltration of fresh-
water (eg, rainwater and pond water) into aquifers to 
Figure 1 Schematic diagram of the managed aquifer recharge systems in southwest coastal Bangladesh.
Figure 2 (A) Groundwater salinity (measured as EC: electrical conductivity) distribution in coastal Bangladesh (data source: 
Bangladesh Water Development Board) and (B) location of the 75 managed aquifer recharge sites in southwest coastal region 
illustrated by red dots (data source: Professor Kazi Matin Uddin Ahmed).
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create a store of freshwater within the naturally brackish 
aquifer (figure 1).15–17 MAR represents a promising 
adaptive strategy for increasing freshwater availability 
and sustaining a year-round drinking water supply that 
is protected from evaporation, and could be resilient 
to tidal storms, cyclones and surface water salinity since 
freshwater infiltration and storage occur under confined 
conditions.18
The brackishness of groundwater in southwest coastal 
Bangladesh is caused by a combination of climatic and 
anthropogenic factors including sea level rise, frequent 
cyclones and tidal storms, and shrimp cultivation.19–22 In 
the future, climate change and sea level rise are expected 
to cause more cyclones, tidal surges and flood in this 
region that will further affect surface water and ground-
water salinity.7 In many areas in southwest coastal Bangla-
desh, both shallow and deep aquifers contain naturally 
brackish water causing acute scarcity of drinking water 
(figure 2).23 2 4 Water salinity in southwest coastal Bangla-
desh follows a clear seasonal pattern─higher in the dry 
season than the wet season.25 Salinity of water bodies 
builds up from October to May, peaking during February 
to early May. After May, salinity decreases sharply due to 
rainfall and increased upstream river flow. People collect 
and use rainwater for drinking and cooking purposes 
during the monsoon when precipitation is intense, but 
during the dry season, they generally rely on pond water 
or saline tube well water.26
The Geology Department of the University of Dhaka, 
in collaboration with Unicef, and the Department of 
Public Health Engineering (DPHE), Government of 
Bangladesh, have piloted 20 small-scale MAR projects 
in three districts of southwest coastal Bangladesh to 
evaluate the feasibility of MAR for drinking water supply 
in rural communities.27 The shallow brackish aquifer 
was the target storage zone that is overlain by Holocene 
clay aquitard of 3–15 m thickness.16 In the pilot phase, 
an average storage of approximately 900 m3 of freshwater 
per year per site was established, sufficient to deliver 15 L 
of safe drinking water per day per household, which can 
fulfil the demand for drinking and cooking for approx-
imately 300 people in 60–70 households during the dry 
season.28 29 The second phase of the MAR project started 
in 2014 aiming to install 75 MAR systems in three districts 
of southwest coastal Bangladesh: Satkhira, Khulna and 
Bagerhat (figure 2B). In March 2016, thirty MAR sites 
were handed over to the community for water consump-
tion. The remaining 45 sites are expected to be ready by 
November 2016 following infiltration of water during 
monsoon of 2016 (June to October 2016).
Epidemiological studies have demonstrated that high 
sodium intake is associated with elevated blood pres-
sure30–32 and other cardiovascular diseases.33 A study 
conducted among the adult population residing in south-
west coastal Bangladesh suggests drinking saline water 
was associated with high blood pressure after adjusting 
for personal, lifestyle and environmental factors.34 
Among study participants, the mean systolic blood pres-
sure for those consuming water with sodium from the 
lowest quintile was 119.4 (SD 13.7) and from the highest 
sodium quintile was 126.7 mm Hg (18.0).34 Excess 
sodium intake from drinking brackish water has been 
also associated with increased gestational hypertension 
and pre-eclampsia among pregnant women in southwest 
coastal Bangladesh.35 36 Mean systolic and diastolic blood 
pressures were higher among the pregnant women who 
Figure 3 Timeline of blood pressure measurement with number of managed aquifer recharge communities and participants in 
preintervention (blue colour) and postintervention (brown colour) time period in different steps. 
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drank tube well or pond (saline sources) water compared 
with those who drank rainwater.35 37 The mean systolic 
blood pressure of pregnant women from these areas 
was 102.4 mm Hg among those who drank rainwater, 
112.6 mm Hg among pond water users and 119.4 mm Hg 
among brackish groundwater users.35 High blood pres-
sure during pregnancy is associated with high maternal 
mortality, and adverse pregnancy and fetal outcomes.38
There are 37 million people living in the southwest 
coastal region and 20 million are currently affected by 
drinking water salinity.39 The estimated mean global 
sodium consumption is 3.95 g/day (range 2.2–5.5 g/
day),40 but people in southwest coastal Bangladesh 
consume up to 16 g of sodium per day through drinking 
brackish groundwater.41 While MAR water can potentially 
reduce exposure to saline water, the health effects of 
providing access to MAR water have not been investigated. 
Characterising the health consequences of shifting from 
current drinking water supply to MAR water can assist 
decision makers to assess the value of scaling up MAR. 
Many water interventions, for example, failed to achieve 
health impact, because people do not use them. There 
is also considerable controversy on whether reducing 
sodium intake improves health.42 In addition, the MAR 
system will also alter the intake of other cations such as 
calcium and magnesium that may have health impact.43–46 
Because the cost of these systems is high and their long-
term feasibility an open question, clarifying the amount 
of health benefit, if any, is an important step that can help 
inform future efforts to provide water to communities 
faced with high levels of groundwater salinity. The human 
subject committees who reviewed the study appreciated 
the uncertainty in bringing solutions to scale in this 
setting and considered it appropriate to include health 
measurements of participating residents to objectively 
evaluate the potential impact.
objectives
Randomised controlled trials demonstrate that reduction in 
dietary sodium in adults decreases blood pressure among 
people both with and without hypertension.47–49 Meta-anal-
ysis of randomised trials also suggests modest reduction in 
salt intake for 4 or more weeks causes significant reduction 
in blood pressure at the population level.50 51 The primary 
objective of the study is to assess whether access to low-sa-
linity MAR water can reduce blood pressure of community 
members ≥20 years of age. Secondary objectives include 
whether access to MAR water can reduce urinary sodium 
and total protein excretion. We will evaluate water salinity, 
urinary sodium excretion and blood pressure so that we 
understand whether or not we achieved our immediate 
targets along the causal pathway.
MEthods
Study design
We will implement a stepped-wedge cluster-randomised 
controlled trial in 16 MAR communities. MAR system 
is a community-based intervention designed to supply 
low-salinity water for 60–70 households in a village or 
community. MAR intervention cannot be implemented 
and randomised at individual or household levels. 
Once a community will have access to MAR water, it is 
difficult to withhold the access of MAR water for some 
households. Therefore, we will conduct a cluster-ran-
domised trial where each community will be considered 
as a cluster. The stepped-wedge design allows communi-
ties to gradually have access to MAR water; however, the 
point at which their access commences will be randomly 
assigned.52 In this way, each MAR site will contribute data 
for both the intervention and the control time periods. 
We will have five monthly steps in the stepped-wedge trial 
(figure 3). In the first step, none of the communities will 
have MAR water available for drinking and we will collect 
baseline information. During each subsequent month, 
four randomly selected communities will receive access 
to MAR water for drinking and cooking. In the last (fifth) 
monthly step, all the communities will have access to 
MAR drinking water.
study settings
The study will be conducted at the community level in 
three districts in southwest coastal Bangladesh─Khulna, 
Satkhira and Bagerhat─where 75 MAR systems have been 
installed. Of these, 30 systems are already in use. We will 
select 16 communities for study based on consultation 
with the implementers of MAR systems (Dhaka Univer-
sity and Unicef Bangladesh). Three criteria need to be 
met for inclusion of communities in the study: commu-
nities have not started drinking MAR water, acceptable 
level of arsenic (<50 µg/L) in drinking water set by the 
government of Bangladesh53 54 and electrical conductivity 
(a measure of salinity) of water below 2000 µS/cm, an 
indication that the MAR system has successfully reduced 
salinity in the aquifer.
Participant eligibility criteria
The inclusion criteria will be household members 
≥20 years old and pregnant women who willingly agree 
to exclusively use MAR water during the dry season for 
drinking and cooking purposes. The Dhaka University 
team have determined the catchment area for each 
MAR site based on geographical distance from MAR 
infrastructure and have developed a list of house-
holds who expressed willingness to drink MAR water. 
Any ≥20-year-old hypertensive household members 
will be also eligible for participation but research 
staff will collect information about their medication if 
any. Research staff will enrol postadolescent ≥20-year 
population as an individual’s response to salt intake 
(salt-sensitivity) increases with age55 and adolescence 
is associated with adrenal and nervous system matu-
ration that may contribute to salt sensitivity.56 57 They 
will approach households living near the MAR water 
access point. They will enrol the 28 closest households 
surrounding each MAR system that meet the inclusion 
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criteria and consent (online supplementary informa-
tion 1) to study participation. During the informed 
written consent process, research staff will inform each 
household that they will be randomly selected when 
to start consuming MAR water as part of the scientific 
process of the study. All household members >20 years 
of age will be eligible and enrolled in the study from 
the selected 28 households. In addition, research staff 
will enrol households that include a pregnant woman in 
each selected MAR catchment community irrespective 
of household selection from a list of pregnant women 
developed by a female promoter.
randomisation and intervention delivery
We will randomly select four MAR communities to 
drink MAR water in each step following the first (base-
line) step (figure 3) by computer-generated random 
numbers. Randomisation will be conducted by an inves-
tigator who will not be directly involved in implemen-
tation of the stepped-wedge study and this will be done 
before commencement of the study. The study could not 
be blinded, therefore there was no concealment from 
the cluster participants. Although infiltration of rain-
water and pond water into the brackish aquifer through 
the MAR systems will be ongoing for 1–2 years in each 
community, people will not have access to MAR water 
until a formal handover of MAR systems to community 
members. The implementers hire a caretaker or gate-
keeper for each MAR community who is responsible 
for maintenance of the respective MAR system prior 
to the community handover. The implementers form a 
community management team who are responsible for 
maintenance of each MAR system following handover. 
We have synchronised the community handover with 
the randomisation schedule in the 16 communities 
after consulting with the gatekeepers. Community 
health promoters will inform the participants when the 
MAR water will be available for consumption once the 
community management team is formed. Agreement 
of the implementers and gatekeepers was sought at the 
beginning of the study during site selection for inclu-
sion of any site in trial and access of MAR water as per 
the randomisation.
We will deploy a local trained promoter at each MAR 
site, who will visit these households, list members and 
identify pregnant women in these and other households 
in catchment areas of each MAR site. Promoters will 
encourage all household members to drink MAR water 
exclusively while they are at home, carry a bottle of MAR 
water while they go out for work and other activities, and to 
cook with MAR water. The community health promoters 
will visit households with promotional materials (eg, flip 
charts) from the beginning of the study to inform house-
hold members about adverse health effects of drinking 
brackish water and potential benefits of drinking low-sa-
linity MAR water. As per the randomisation schedule, they 
will inform households when MAR water will be available 
for consumption.
sample size
The sample size of the stepped-wedge trial was calcu-
lated based on the effect of MAR systems to reduce 
systolic blood pressure of the ≥20-year-old community 
members. Data from southwest coastal Bangladesh 
demonstrated a 7 mm Hg lower mean systolic blood 
pressure among pregnant women who drank pond 
water compared with those who drank brackish water, 
and a 17 mm Hg lower mean systolic blood pressure for 
pregnant women who drank rainwater compared with 
those who drank brackish water.35 The mean reduction 
in systolic blood pressure following long-term modest 
salt reduction is 4.2 mm Hg.50 For calculations, we 
considered a mean systolic blood pressure reduction of 
at least 3 mm Hg among the communities who will have 
access to MAR water for drinking and cooking purposes 
compared with those who will use brackish water. The 
entire population under the MAR community catch-
ment area will be considered as one cluster. Each MAR 
community serves approximately 300 people, consti-
tuting 60–70 households in the catchment area.28 The 
mean household size in southwest coastal Bangladesh 
is 4.2, approximately 52% of household members are 
≥20 years old.58 59 Since we will collect blood pressure 
from all household members ≥20 years old, we esti-
mated an average of 2.2 participants in this age group 
per household. We will select 28 households per cluster 
(28×2.2=60 people per cluster). A previously published 
study in Bangladesh reported SD 13.51 for systolic 
blood pressure,60 but we considered SD 20 for systolic 
blood pressure to capture a greater variation of blood 
pressure. We calculated the sample size for the stepped-
wedge trial adopting the formula used by Hussey and 
Hughes.61 Although their formula assumed no with-
in-participant correlation over time (cross-sectional 
design), we applied their formula for a cohort design 
(same participant followed up over time). The salinity 
problem and the MAR water quality may be influenced 
by seasonality over the progression of dry season and 
participants’ blood pressure may respond differently 
to different level of sodium exposure in MAR drinking 
water. Therefore, it is important that we investigate 
the effect of the MAR system on the same participants 
over the entire dry season. Since we will investigate the 
same participants in each step, we will have less partic-
ipant-level variability and sufficient power compared 
with a cross-sectional design to investigate the effect of 
MAR systems. We initially calculated the sample size for 
a simple unadjusted trial (NU), and then multiplied by 
the design effect for a stepped-wedge trial (DESW). The 
sample size for a simple unadjusted trial was calculated 
as 1396 participants (effect size=3, SD of 20 for both 
groups, 80% power and 5% type I error). The DESW was 
3.04 based on a formula provided by Hussy and Hughes, 
therefore sample size was 1396×3.04. We also inflated 
the total sample size considering 10% loss to follow-up. 
We then followed the approaches of determining 
the number of clusters required for total sample size 
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considering a fixed cluster size of 60.62 We then calcu-
lated the number of steps that we need to randomise by 
dividing the total cluster by steps. We calculated that 16 
MAR communities will be required for the study with 
four communities randomised to access MAR water in 
each step (figure 3).
data collection methods
The outcomes of interest will be measured from selected 
participants of 16 communities irrespective of their 
access to MAR water during five monthly visits. The 
interval between two successive blood pressure measure-
ments or two consecutive data collection visits will be at 
least 4 weeks for each participant. After taking informed 
written consent from household heads and each partici-
pant, research staff will administer a survey using a struc-
tured questionnaire to collect information on drinking 
water sources, household members’ sociodemographic 
status, medical history, family history of cardiovascular 
diseases, medication intake, and cardiovascular risk 
factors including smoking history and alcohol intake 
during the first monthly visit. Exposure and outcome data 
will be collected in all five visits. Participants’ weight and 
hip circumference will be measured in all visits but height 
will be measured in one visit.
As part of the MAR uptake evaluation, the research 
staff will collect self-reported data on MAR water use from 
each household and whether households exclusively or 
intermittently use MAR water for drinking and cooking 
during follow-up visits. Research staff will also collect 
stored drinking and cooking water samples for measure-
ment of electrical conductivity and will ask respondents 
the source of stored water.
Exposure assessment
During each visit, research staff will inquire about house-
hold members’ reported primary water sources used 
for drinking and cooking purposes in the last 24 hours, 
collect reported information on whether participants 
exclusively used the primary water sources and explore 
whether any alternative water sources were used. They 
will also ask about the frequency of collection and cost 
of primary water sources for drinking and cooking, time 
required to collect water, amount of collected water and 
when the last water was collected. Research staff will 
observe the presence of stored water in households, ask 
the sources of each container of stored water and will 
collect water samples that have been stored for drinking 
and cooking (if any) to measure the salinity level, elec-
trical conductivity, resistivity, total dissolve solutes and 
temperature using Hanna® Salinity meter. They will also 
collect the MAR water from the source MAR outlet to 
measure the salinity level, electrical conductivity, resis-
tivity, total dissolved solutes and temperature. Research 
staff will collect 24 hours urine from each participant 
to measure the urinary sodium excretion as a proxy for 
sodium intake.63 64
outcomes assessment
Systolic blood pressure of the ≥20-year-old participants is 
the primary outcome of this study. Secondary outcomes 
will be diastolic blood pressure, mean arterial pressure 
and pulse pressure (table 1). The different components 
of blood pressure are independent cardiovascular risk 
factors associated with sodium intake,65–69 and indicate 
future risk for different cardiovascular diseases.70 High 
systolic blood pressure puts more stress on the vascular 
wall and is strongly associated with risk for future intrace-
rebral haemorrhage, subarachnoid haemorrhage, angina, 
myocardial infarction and peripheral vascular diseases.70 
Raised diastolic blood pressure is associated with aortic 
and thoracic aneurysm.70 Some effects of high sodium 
intake are independent of high systolic and diastolic 
blood pressures such as arterial stiffness and left ventric-
ular mass─both are independent predictors of future 
cardiovascular diseases. High pulse pressure (difference 
between systolic and diastolic blood pressures) is associ-
ated with increased arterial stiffness,66 68 and high mean 
arterial pressure (diastolic blood pressure plus one-third 
Table 1 Study outcomes including normal ranges of blood pressure and biomarkers
Outcomes
Study population
Measures Normal range/calculation
≥20 years 
old
Pregnant 
women
Primary outcome: systolic 
blood pressure
Yes Yes Systolic blood pressure 90–140 mm Hg
Secondary outcomes: 
diastolic blood pressure
Yes Yes Diastolic blood pressure 60–90 mm Hg
Mean arterial pressure Yes Yes Mean arterial pressure Diastolic blood pressure + one-
third systolic blood pressure
Pulse pressure Yes Yes Pulse pressure Systolic blood pressure − 
diastolic blood pressure
Tertiary outcomes: urinary 
sodium excretion
Yes Yes Urinary sodium-creatinine ratio 40–220 mEq/L/24 hours
Proteinuria Yes Yes Urinary protein-creatinine ratio <0.11 mg/mg
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of systolic blood pressure) and high pulse pressure are 
independently associated with increased left ventricular 
mass.66 68
We will also measure the creatinine adjusted protein 
excretion of all participants as tertiary outcomes (table 1). 
Proteinuria is a biomarker for future risk of cardiovas-
cular diseases,71–74 and is associated with the pathogenesis 
of cardiovascular diseases, including hypertension,75 76 
chronic kidney disease,77 myocardial ischaemia,78 carotid 
artery thickness,79 80 left ventricular hypertrophy,81 82 
hyperlipidaemia,83 atherosclerosis84 and coronary artery 
calcification.72 80 85 86 Reduced salt intake for 4 weeks has 
been associated with decreased proteinuria in blinded 
randomised controlled trial.87 Pre-eclampsia is associated 
with high maternal mortality and adverse pregnancy and 
fetal outcomes38 and is characterised by high blood pres-
sure and proteinuria after 20 weeks of pregnancy.88
blood pressure measurement
Blood pressure will be measured for all >20-year-old partic-
ipants and pregnant women during each step. Research 
staff will use an Omron HEM-907 blood pressure device, 
which is comparable to the gold standard mercury sphyg-
momanometers in terms of measurement and meets 
the Association for the Advancement of Medical Instru-
mentation’s criteria.89 Blood pressure will be measured 
following the guidelines described by Pickering et al and 
Giorgini et al.90 91 Caffeine (tea, coffee, carbonated bever-
ages), eating, heavy physical activities and smoking will be 
proscribed for 30 min prior to measuring blood pressure. 
Participants will rest for 5 min sitting on a chair keeping 
their arm supported. An appropriate size cuff and cali-
brated instrument will be used for different age groups 
and the blood pressure instrument will be positioned at 
heart level. Blood pressure will be measured three times; 
first left arm, then right arm, then again left arm. Both 
systolic and diastolic blood pressures will be recorded 
from all measurements. The arithmetic mean of three 
systolic blood pressure measurements will be used as the 
primary outcome. However, if a systolic blood pressure 
measurement differs by 10% from the other measure-
ments, that measurement will be excluded when calcu-
lating the arithmetic mean systolic blood pressure.
biomarker measurements
Field research staff will instruct the participants to 
collect 24 hours urine sample during each household 
visit. The volume of the urine samples will be noted at 
household level, and a sample of 25 mL urine will be 
collected and transported to the field laboratory at 2–8°C 
within 6 hours of collection for processing, analysis and 
storage. Aliquots of each participant’s urine sample will 
be made for biochemical and electrolyte measurements. 
Urinary creatinine concentration will be measured by 
a colorimetric method (Jaffe reaction) using a semi-
auto biochemistry analyser (Evolution 3000, BSI, Italy). 
Urinary total protein will be estimated using a light sensi-
tive coloured reagent (Randox, UK). We will use the 
direct ion selective electrode method for urinary sodium 
measurements using a semiauto electrolyte analyser 
(Biolyte2000, Bio-care, Taiwan). We will measure the uric 
acid concentration in blood by an enzymatic colorimetric 
method (Evolution 3000, BSI). We will perform routine 
quality control for all tests using standard quality control 
reagents (Bio-Rad Laboratories, USA) and 5% of samples 
will be cross-checked at the International Centre for Diar-
rhoeal Disease Research, Bangladesh (icddr,b) central 
laboratory in Dhaka.
data management and monitoring
The data collection instrument will be programmed and 
field research staff will use handheld computers to collect 
data. Appropriate range values and data values will be 
programmed to minimise data entry errors. The data 
set downloaded from handheld devices will be cleaned 
and checked by the site investigators. All laboratory data 
will be double entered. Data will be stored in icddr,b’s 
data repository system, in compliance with the system’s 
requirements and will be publicly available after analysing 
the primary result.
The research staff will be trained for identifying 
adverse events such as hypertension and hyperten-
sive disorders in pregnancy. They will report to the 
investigators following identification of these patients 
and the investigators will assess whether these adverse 
events need to be reported to icddr,b's Ethical Review 
Committee.
statistical methods
We will conduct an intention-to-treat analysis for the 
primary analysis. For the primary analysis, we will assess 
whether access to MAR water reduces the systolic blood 
pressure (continuous outcome) of the ≥20-year-old partic-
ipants. Pregnant women will be included in the primary 
analysis because it is likely few pregnant women will be 
identified in the 16 communities and separate analysis 
of pregnant women will be underpowered. We will use 
generalised linear mixed models with appropriate links 
for the primary analysis considering random effects 
for community, households and participants, and fixed 
effects of steps or visits. We will adjust the effect of MAR 
systems on blood pressure for age, sex, weight and height, 
and personal and socioeconomic factors (table 2). We will 
inspect the missing data patterns and use multiple impu-
tation with chained equations to jointly impute data on 
missing exposure and confounders to preserve an unbi-
ased association estimate if the data are missing at random 
conditional on measured variables. We will also conduct 
subgroup analyses among the households that adhere 
with the MAR intervention and that exclusively use MAR 
water. If the trial demonstrates drinking MAR water has 
health effects, we will investigate the time required for 
health effects following receiving MAR intervention in 
secondary analysis.
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Ethics
Informed written consent will be taken from all partici-
pants and household heads. Consent will be also taken 
for ancillary studies and future use of specimens collected 
from study participants. This study protocol has been 
reviewed and approved by the icddr,b Ethical Review 
Committee. Approval will be taken for any addition or 
modification of the protocol from icddr,b Ethical Review 
Committee. If research staff members identify patients 
with hypertension or cases of hypertension during preg-
nancy, they will refer patients to the local government 
health facilities for further management. In addition, 
research staff will train pregnant women and family 
members to recognise the danger signs during preg-
nancy, and will also instruct them where to seek medical 
care if such danger signs appear. During monthly house-
hold visits, research staff will encourage pregnant women 
to attend prenatal visits. All data sets will be anonymous 
without the personal identifiers and participants’ privacy 
will be maintained during data storage, analysis and 
dissemination.
dissemination
Study findings will be shared with the DPHE, Department 
of Environment of the government of Bangladesh and 
other partner non-governmental organisations working 
in southwest coastal Bangladesh for access to safe drinking 
water. We will discuss the scope and limitations of the 
MAR system to address the demand of safe drinking water 
based on findings from this study. We will be submitting 
abstracts to international conferences for dissemination 
to the international audience working on safe water. We 
will develop manuscripts and submit to peer-reviewed 
journals to publish our research.
dIsCussIon
This will be the first study to assess the health impact of an 
environmental intervention to reduce groundwater salinity 
in southwest coastal Bangladesh. Our study has several 
strengths. The stepped-wedge trial ensures that we will have 
counterfactual data as well as gradual access to MAR water 
in all communities. In a stepped-wedge design, treatment 
effect of an intervention can be estimated from between 
and within-cluster comparisons as participants will act as 
their own control, compared with only between-cluster 
comparison in a parallel cluster-randomised design.61
We explored other study designs such as non-ran-
domised study. As per suggestion of icddr,b’s Ethical Review 
Committee, we conducted a pilot study in four communities 
(two MAR communities and two non-MAR communities) 
from May to August 2016. Pilot study findings suggested that 
because of the heterogeneity in village-level hydrogeolog-
ical conditions and in participation by community residents 
with different characteristics, non-randomised quasiexper-
imental studies would be expected to generate unequal 
distribution of confounders that would undermine scien-
tific inference. The objective of the pilot study was to pretest 
our data collection instrument laboratory protocols prior 
commencement of the main study. We identified unequal 
distributions of several important observed confounders 
across the communities such as socioeconomic status, and 
household characteristics such as supply of electricity and 
ownership refrigerator. We identified that some covariates 
such as supply of electricity were perfectly predictive of 
communities receiving MAR interventions. We were unable 
to derive satisfactory matching of MAR intervention and 
control households after principal component analysis. 
The findings highlighted the importance of a randomised 
Table 2 Key variables to be used for assessing the health impact of access to MAR water
Outcomes Exposures Confounders Covariates Moderators
Systolic blood pressure Access to MAR water Sex Age Drinking/cooking from 
another water sources
Diastolic blood pressure Drinking water salinity Socioeconomic 
status
Weight
Pulse pressure Cooking water salinity Education Height
Mean arterial pressure Drinking water sources
Cooking water sources
Waist circumference
Urinary total protein
Urinary sodium excretion
Mid-upper arm 
circumference
Adding table salt
Adding salt for cooking
Exercise level
Smoking status
Use of betel nuts
Stress
Diet
Urinary creatinine
MAR, managed aquifer recharge.
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trial to evaluate the health effects of MAR systems since 
there are many observed and unobserved household and 
community-level and hydrogeological confounders that 
may influence blood pressure.
We also explored the possibilities of parallel group 
randomised trial but several programmatic issues barred 
us to implement a parallel group cluster-randomised 
trial. The implementers of MAR systems (Unicef Bangla-
desh and University of Dhaka) installed the 75 new sites 
in different stages and planned to allow communities to 
access these over three dry seasons. The implementers 
informed us that 20–25 MAR sites may be suitable for 
community access during our study period and they 
wanted to allow all communities to drink MAR water in 
the same season after satisfactory reduction in salinity. 
Therefore, a parallel group cluster-randomised trial was 
not suitable as we could not randomly select control sites 
and postpone the community to drink water for the dry 
season. We believe that the stepped-wedge trial design 
was appropriate to obtain counterfactual data as well as 
fulfilling the programmatic need.
We will use the same instruments for data collection 
and outcome measurements for all steps for exposed 
and unexposed communities, which will mitigate bias 
in data collection. Measurement of water source salinity 
and urinary sodium concentration will explain the 
biologically plausible effect of drinking MAR water on 
blood pressure. All outcomes planned to measure in the 
study are objective outcomes that will reduce the risk 
of reporting bias. Collection of detailed exposure and 
covariate data will help in determining a valid association 
between drinking MAR water and health benefits. We 
will have several outcome variables and biomarkers that 
will ensure a comprehensive health benefit evaluation of 
access to MAR water.
The study has several limitations. We will be unable to 
control salinity level of drinking water across the 16 MAR 
communities due to different hydrogeological condi-
tions and volume of infiltrated water across the aquifers. 
Although the initial electrical conductivity of MAR water 
will be <2000 µS/cm, electrical conductivity is likely to vary 
across different MAR communities with the intensification 
of dry season. Therefore, MAR water salinity will differ 
across communities at a single point of time, and also for 
the same community at different points of time. This will 
result in different versions of exposures (ie, access to MAR 
water with different salinity levels) that may affect different 
responses for some participants depending on the version 
of exposure they will receive.92 93 To account this, we will 
specify the versions of exposure by measuring the salinity 
level of MAR water available in participants’ households and 
interpret the response as unit change of salinity at different 
MAR water salinity levels. As compliance of drinking MAR 
water may be different across communities despite active 
encouragement by promoters, one problem of the inten-
tion-to-treat analysis is that if the proportions of participants 
who will always drink MAR water are low compared with 
those who will not, the potentially greater effect of MAR 
intervention on blood pressure of fully participating indi-
viduals may be washed out by the smaller effect of those who 
will not comply. To account for this, as a secondary analysis, 
we will conduct ‘instrumental variable’ (IV) analyses by 
jointly running two regression models: a regression model 
for predicting urinary sodium excretion by drinking water 
salinity, and a regression model for blood pressure predic-
tion given the urinary sodium excretion. The assumption of 
IV analyses is fulfilled in our context as the exogenous vari-
able (IV) can only affect outcome variable (blood pressure) 
through influencing the endogenous variable (urinary 
sodium excretion).94 If MAR water has lower salinity than 
other water sources and if participants always drink MAR 
water, their urinary sodium excretion will be low compared 
with those who will not fully participate.
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